DrugPatentWatch Database Preview» See Plans and Pricing
« Back to Dashboard
Trientine hydrochlorideis the generic ingredient in three branded drugs marketed by Kadmon Pharms Llc, Bausch, Amneal Pharms Llc, Dr Reddys Labs Ltd, Lupin Ltd, MSN, Navinta Llc, Par Pharm Inc, Rising, Watson Labs Teva, and Zydus Pharms, and is included in twelve NDAs. Additional information is available in the individual branded drug profile pages.
There are ten drug master file entries for trientine hydrochloride. Thirteen suppliers are listed for this compound.
Recent Clinical Trials for trientine hydrochloride
Identify potential brand extensions & 505(b)(2) entrants
|Alexion Pharmaceuticals||Phase 2|
|GMP-Orphan SAS||Phase 3|
|University of British Columbia||Phase 2|
Pharmacology for trientine hydrochloride
|Drug Class||Metal Chelator |
|Mechanism of Action||Metal Chelating Activity |
Medical Subject Heading (MeSH) Categories for trientine hydrochloride
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Zydus Pharms||TRIENTINE HYDROCHLORIDE||trientine hydrochloride||CAPSULE;ORAL||211554-001||Apr 26, 2019||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Dr Reddys Labs Ltd||TRIENTINE HYDROCHLORIDE||trientine hydrochloride||CAPSULE;ORAL||211076-001||Jul 3, 2019||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Navinta Llc||TRIENTINE HYDROCHLORIDE||trientine hydrochloride||CAPSULE;ORAL||211251-001||Jan 16, 2019||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|Par Pharm Inc||TRIENTINE HYDROCHLORIDE||trientine hydrochloride||CAPSULE;ORAL||210096-001||Sep 25, 2019||AB||RX||No||No||Start Trial||Start Trial||Start Trial|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|
Make Better Decisions: Try a trial or see plans & pricing
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.